Prof. Minggui Wang (Shanghai, China)
Prof. Minggui Wang serves as the Director of the Institute of Antibiotics at Huashan Hospital, Fudan University, where he holds positions as a Professor, Chief Physician, and Doctoral Supervisor. He is also the founding Chairman of the Chinese Society of Bacterial Infection and Resistance and a standing committee member of the Chinese Society of Infectious Diseases under the Chinese Medical Association. Additionally, he serves as the Deputy Director of the Infectious Diseases Society of China and holds various positions in national and international societies focusing on infection control and clinical microbiology, including the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society for Antimicrobial Chemotherapy (ISAC).
Prof. Wang has been recognized as a Leading Talent in Shanghai and honored as an Outstanding Academic Leader in the city. His research interests focus on the diagnosis and treatment of bacterial and fungal infections, as well as the rational use of antimicrobial agents. His research on drug-resistant microorganisms has received funding from prestigious sources such as the National Basic Research Program (973 Program), Major Programs of the National Natural Science Foundation of China, and the National Institutes of Health.
Prof. Minggui Wang serves as the Director of the Institute of Antibiotics at Huashan Hospital, Fudan University, where he holds positions as a Professor, Chief Physician, and Doctoral Supervisor. He is also the founding Chairman of the Chinese Society of Bacterial Infection and Resistance and a standing committee member of the Chinese Society of Infectious Diseases under the Chinese Medical Association. Additionally, he serves as the Deputy Director of the Infectious Diseases Society of China and holds various positions in national and international societies focusing on infection control and clinical microbiology, including the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society for Antimicrobial Chemotherapy (ISAC).
Prof. Wang has been recognized as a Leading Talent in Shanghai and honored as an Outstanding Academic Leader in the city. His research interests focus on the diagnosis and treatment of bacterial and fungal infections, as well as the rational use of antimicrobial agents. His research on drug-resistant microorganisms has received funding from prestigious sources such as the National Basic Research Program (973 Program), Major Programs of the National Natural Science Foundation of China, and the National Institutes of Health.